Sight Sciences Inc (NAS:SGHT)

Q1 2025 Sight Sciences Inc Earnings Call Transcript

May 8, 2025 / 08:30 PM GMT

Release Date Price: $3.03 (+5.94%)

Transcript 10-Q8-K

Key Points

Positve

Sight Sciences Inc (SGHT) reported a total revenue of $17.5 million for the first quarter of 2025, reflecting solid performance in a dynamic MIGS market.
The company is focused on addressing unmet medical needs in glaucoma and dry eye markets, with a commitment to developing transformative interventional technologies.
Sight Sciences Inc (SGHT) has launched the next-generation Omni Edge, which has been well-received by surgeons and is expected to enhance their product portfolio.
The company is actively working on establishing additional manufacturing locations outside of China to mitigate tariff impacts, which should lower costs over time.
Sight Sciences Inc (SGHT) has trained approximately 50% of MIGS-trained surgeons in the United States, indicating strong market penetration and educational outreach.

Negative

The company experienced a 9% decrease in total revenue compared to the same period in the prior year, primarily due to changes in Medicare coverage affecting the MIGS market.
Tariff increases on goods imported from China are expected to raise the cost of goods sold, impacting financial performance throughout 2025.
Dry eye revenue decreased to $0.4 million from $1 million in the same period in the prior year, attributed to fewer smart lid sales following a price increase.
Sight Sciences Inc (SGHT) has not yet achieved reimbursement coverage for its tier care procedure, which is crucial for driving growth in the dry eye segment.
The company reported a net loss of $14.2 million for the first quarter, although this was an improvement from the previous year's loss.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SGHT.OQ - Sight Sciences Inc
Q1 2025 Sight Sciences Inc Earnings Call
May 08, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by.

Welcome to the site Sciences, first quarter of 2025, earning results, conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you will need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press 11 again.

Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Hannah Jeffries, Investor relations, please go ahead.

-----------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.